| Schedule of Financial Income and Expenses |
Financial income: | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | 2023 | | 2024 | | 2025 | | | (in thousands) | | Income from short-term investments and term deposits and other finance revenue | $ | 177 | | | $ | 850 | | | $ | 1,401 | | | Gain on debt extinguishment (Note 17.1) | 247 | | | 13,952 | | | — | | | Change in fair value of derivative financial instruments (Note 17.1) | 3,200 | | | 3 | | | 45,000 | | | Foreign exchange gain | 1,166 | | | 3,037 | | | 4,161 | | | Total financial income | $ | 4,790 | | | $ | 17,842 | | | $ | 50,562 | |
Financial expenses: | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | 2023 | | 2024 | | 2025 | | | (in thousands) | | Interest on loans | $ | 9,584 | | | $ | 22,465 | | | $ | 11,140 | | | Interest on lease contracts (see Note 18) | 479 | | | 321 | | | 229 | | | Interest on financing component of revenue contracts (see Notes 21 and 22) | 115 | | | 69 | | | 715 | | | Loss on debt extinguishment (Note 17.1) | — | | | — | | | 29,348 | | | Interest on supplier payable with extended payment terms | 286 | | | 142 | | | — | | | Other bank fees and financial charges | 946 | | | 731 | | | 414 | | | Foreign exchange loss | 1,858 | | | 2,543 | | | 5,271 | | | Total financial expenses | $ | 13,268 | | | $ | 26,271 | | | $ | 47,117 | |
|
| Schedule of Cost of Revenue and Operating Expenses |
The tables below present the cost of revenue and operating expenses by nature of expense: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | | Note | | 2023 | | 2024 | | 2025 | | | | | | (in thousands) | | Included in cost of revenue: | | | | | | | | | | Cost of components | | | | $ | 5,071 | | | $ | 5,846 | | | $ | 7,519 | | | Depreciation and impairment | | 9 | | 395 | | | 289 | | | 527 | | | Amortization of intangible assets | | 10 | | 118 | | | 164 | | | 170 | | | Wages and benefits | | | | 2,059 | | | 1,341 | | | 1,224 | | | Share-based payment expense | | 16 | | 131 | | | 84 | | | 19 | | | Assembly services, royalties and other | | | | 1,702 | | | 1,368 | | | 2,754 | | | | | | $ | 9,476 | | | $ | 9,092 | | | $ | 12,213 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | | Note | | 2023 | | 2024 | | 2025 | | | | | | (in thousands) | | Included in operating expenses (income) (between gross profit and operating result): | | | | | | | | | | Gain on sale of 4G intangible and tangible assets, net | | 4 | | — | | | (153,129) | | | $ | — | | | Depreciation and impairment | | 9 | | $ | 4,082 | | | $ | 2,814 | | | 2,197 | | | Amortization of intangible assets | | 10 | | 7,346 | | | 4,145 | | | 2,784 | | | Impairment of 5G broadband platform intangible and tangible assets | | | | — | | | 56,633 | | | — | | | Digital assets impairment losses | | 11 | | — | | | — | | | 67,375 | | | Digital assets losses on sales, net | | 11 | | — | | | — | | | 6,102 | | | Wages and benefits | | | | 36,014 | | | 39,637 | | | 29,642 | | | Share-based payment expense | | 16 | | 6,973 | | | 4,006 | | | 2,992 | | | Foreign exchange (gains) losses related to hedges of euro | | | | (180) | | | (47) | | | 144 | | | Rent, supplies, external services and other, net of capitalization of research and developments costs | | | | (257) | | | 4,147 | | | 14,768 | | | | | | $ | 53,978 | | | $ | (41,794) | | | $ | 126,004 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | | Note | | 2023 | | 2024 | | 2025 | | | | | | (in thousands) | | Wages and salaries | | | | $ | 28,863 | | | $ | 31,458 | | | $ | 23,972 | | | Social security costs and other payroll taxes | | | | 9,087 | | | 9,270 | | | 6,895 | | | Other benefits | | | | 159 | | | 171 | | | 112 | | | Pension costs | | | | (36) | | | 79 | | | (113) | | | Share-based payment expenses | | 16 | | 7,104 | | | 4,090 | | | 3,011 | | | Total employee benefits expense | | | | $ | 45,177 | | | $ | 45,068 | | | $ | 33,877 | |
|
| Schedule of Research and Development Expense |
The impact of the reduction of research and development expense due to government grants, research tax credit and development costs capitalized was as follows: | | | | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | | 2023 | | 2024 | | 2025 | | | | (in thousands) | | Research and development costs | | $ | 53,018 | | | $ | 47,566 | | | $ | 37,018 | | | Research tax credit | | (5,374) | | | (3,821) | | | (1,714) | | | Government and other grants | | (1,834) | | | (1,939) | | | (4,062) | | | Development costs capitalized (*) | | (22,328) | | | (15,485) | | | (120) | | | Amortization of capitalized development costs | | 2,642 | | | 2,206 | | | 61 | | | Total research and development expense | | $ | 26,124 | | | $ | 28,527 | | | $ | 31,183 | |
|